- Home
- VLO vs TAK Comparison
VLO vs TAK Comparison
Compare VLO & TAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VLO
- TAK
- Stock Information
- Founded
- VLO 1980
- TAK 1781
- Country
- VLO United States
- TAK Japan
- Employees
- VLO N/A
- TAK N/A
- Industry
- VLO Integrated oil Companies
- TAK Biotechnology: Pharmaceutical Preparations
- Sector
- VLO Energy
- TAK Health Care
- Exchange
- VLO Nasdaq
- TAK Nasdaq
- Market Cap
- VLO 42.8B
- TAK 42.2B
- IPO Year
- VLO N/A
- TAK N/A
- Fundamental
- Price
- VLO $134.67
- TAK $14.07
- Analyst Decision
- VLO Buy
- TAK
- Analyst Count
- VLO 14
- TAK 0
- Target Price
- VLO $152.58
- TAK N/A
- AVG Volume (30 Days)
- VLO 3.2M
- TAK 1.8M
- Earning Date
- VLO 01-30-2025
- TAK 01-30-2025
- Dividend Yield
- VLO 3.35%
- TAK 3.63%
- EPS Growth
- VLO N/A
- TAK 15.39
- EPS
- VLO 8.58
- TAK 0.83
- Revenue
- VLO $129,881,000,000.00
- TAK $29,124,927,177.00
- Revenue This Year
- VLO N/A
- TAK $7.80
- Revenue Next Year
- VLO $3.13
- TAK $0.36
- P/E Ratio
- VLO $15.70
- TAK $33.80
- Revenue Growth
- VLO N/A
- TAK 9.83
- 52 Week Low
- VLO $116.84
- TAK $12.58
- 52 Week High
- VLO $184.79
- TAK $15.08
- Technical
- Relative Strength Index (RSI)
- VLO 49.26
- TAK 64.16
- Support Level
- VLO $128.30
- TAK $13.66
- Resistance Level
- VLO $139.88
- TAK $13.97
- Average True Range (ATR)
- VLO 4.67
- TAK 0.13
- MACD
- VLO -0.26
- TAK 0.06
- Stochastic Oscillator
- VLO 40.24
- TAK 96.15
About VLO Valero Energy Corporation
Valero Energy is one of the largest independent refiners in the United States. It operates 15 refineries, with a total throughput capacity of 3.2 million barrels a day in the US, Canada, and the United Kingdom. Valero also owns 12 ethanol plants with capacity of 1.6 billion gallons a year and holds a 50% stake in Diamond Green Diesel, which has the capacity to produce 1.2 billion gallons per year of renewable diesel.
About TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.3 trillion in fiscal 2023. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the US, 20% from Japan, 20% from Europe and Canada.